For instance, anti-VEGF therapy may modulate immune cell infiltration, as well as the intra-tumoral and serum cytokine levels in preclinical models of breast cancer [25], suggesting that anti-VEGF therapies might function as modulators of antitumor immunity. Here, VEGFA is linked to breast cancer.